FIELD: pharmaceutical industry. SUBSTANCE: agent has succinic acid bound with salbutamol in the form of complex - salbutamol hemisuccinate. New active substance is placed in semipermeable shell exhibiting the varying hole diameter to deliver an active component in patient organism and providing the varying dose of an active component in core. Agent shows the increased biological availability, decreased by-side effects, increased rate of effective concentration attainment and concentration level in organism. EFFECT: enhanced effectiveness of agent. 4 cl, 1 dwg, 1 tbl
Authors
Dates
1997-11-27—Published
1996-03-05—Filed